Crescent Capital BDC (FCRX) Cash & Equivalents (2021 - 2026)

Crescent Capital BDC (FCRX) has 6 years of Cash & Equivalents data on file, last reported at $6.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 48.98% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (down 48.98% YoY), and the FY2025 full-year result was $5.0 million, down 50.22% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $6.1 million, up from $5.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $21.4 million in Q1 2023 and bottomed at $1.1 million in Q2 2025.
• The 5-year median for Cash & Equivalents is $6.7 million (2024), against an average of $7.9 million.
• Peak annual rise in Cash & Equivalents reached 181.23% in 2025, while the deepest fall reached 89.73% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $6.4 million in 2022, then rose by 21.62% to $7.8 million in 2023, then soared by 30.21% to $10.1 million in 2024, then tumbled by 50.22% to $5.0 million in 2025, then grew by 21.73% to $6.1 million in 2026.
• The last three Cash & Equivalents figures came in at $6.1 million (Q1 2026), $5.0 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.

Peer Comparison